Immunosuppressive Agents: all 5,940 studies that test it
Page 49 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
- Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and LeukemiaCompletedNCT00665990Phase 1
- Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate CancerStatus unknownNCT00657982Phase 2
- Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple MyelomaCompletedNCT00657488Phase 2/3
- Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00657007Phase 1
- Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) LymphomaCompletedNCT00656812Phase 2
- Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular EdemaCompletedNCT00656643Phase 2
- Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal CancerCompletedNCT00656123Phase 1
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ UltrasoundCompletedNCT00655512Phase 1
- Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)CompletedNCT00655343Phase 3
- Bioavailability Study of Leflunomide Tablets Under Fed ConditionsCompletedNCT00653003Phase 1
- Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00652691Phase 1
- Bioavailability Study of Leflunomide Tablets Under Fasting ConditionsCompletedNCT00652665Phase 1
- Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple MyelomaCompletedNCT00652041Phase 4
- A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant PatientsCompletedNCT00650468Phase 4
- Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mgCompletedNCT00648336Phase 1
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
- Freiburg ZNS-NHL StudyStatus unknownNCT00647049Phase 2
- The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious UveitisTerminatedNCT00646425Phase 2
- Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple MyelomaTerminatedNCT00644306Phase 3
- Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNCT00643071Phase 3
- Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaCompletedNCT00641381Phase 1
- Leflunomide in Systemic Lupus ErythematosusCompletedNCT00637819Phase 2
- Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)CompletedNCT00637143Phase 4
- Everolimus (RAD001) in Elderly Patients With Acute Myeloid LeukemiaStatus unknownNCT00636922Phase 1
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)CompletedNCT00633542Phase 3
- Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric CancerCompletedNCT00632268Phase 2
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerCompletedNCT00627666Phase 2
- Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With PrednisoloneCompletedNCT00626678Phase 2
- Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaCompletedNCT00626483Phase 1
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryCompletedNCT00626015Phase 1
- A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00622258Phase 1
- Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy SubjectsCompletedNCT00621699Phase 1
- Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaCompletedNCT00621452Phase 1
- Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy SubjectsCompletedNCT00621101Phase 1
- Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaWithdrawnNCT00621036Phase 2
- A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation PatientsCompletedNCT00619398Phase 3
- Oral OKT3 in Combination With Beta-D-GlucosylceramideStatus unknownNCT00619372Phase 1
- Everolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00618345Phase 2
- Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityCompletedNCT00617370Not applicable
- Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)CompletedNCT00615667Phase 3
- Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisCompletedNCT00615173Phase 3
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3
- Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaTerminatedNCT00612612Phase 1
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell TransplantationCompletedNCT00612274Early Phase 1
- Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisCompletedNCT00610142Phase 2
- Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver TransplantationCompletedNCT00609388Phase 4
- Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNCT00608673Not applicable
- Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic LymphomaCompletedNCT00608374Phase 3
- Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisCompletedNCT00607581Phase 2
- CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal ImpairmentCompletedNCT00604357Phase 3
- Thalidomide Versus Bortezomib in Melphalan Refractory MyelomaCompletedNCT00602511Phase 3
- Bioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsCompletedNCT00602134Not applicable
- Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control StudyWithdrawnNCT00600301Phase 3
- Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow upCompletedNCT00596557Phase 4
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCompletedNCT00596206Phase 3
- Intraoperative Versus Postoperative Thymoglobulin in Lung TransplantationWithdrawnNCT00592306Phase 3
- A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)CompletedNCT00592111Phase 2
- An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)Status unknownNCT00589901Phase 2
- Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)CompletedNCT00587873Phase 2
- BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)CompletedNCT00586443Phase 1
- Interaction Study of Rapamycin and Sunitinib in Patients With Advanced CancersCompletedNCT00583063Early Phase 1
- Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith EtanerceptCompletedNCT00581165Phase 4
- Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate AloneCompletedNCT00579644Phase 3
- Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque TestCompletedNCT00578370Phase 1/2
- A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)WithdrawnNCT00577668Phase 2
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.CompletedNCT00576433Phase 4
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHDCompletedNCT00574470Phase 4
- Erlotinib and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00574366Phase 1
- UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total TherapyActive, not recruitingNCT00572169Phase 3
- Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaCompletedNCT00569985Phase 1
- A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus NephritisStatus unknownNCT00569101Phase 2
- A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
- Topical Cyclosporine and Disease ProgressionCompletedNCT00567983Phase 4
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567918Phase 3
- Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567762Phase 3
- Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast CancerCompletedNCT00567554Phase 3
- A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseCompletedNCT00565981Phase 2
- Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's ContractureCompletedNCT00565019Phase 3
- A Study of Thymoglobulin and Tacrolimus in Liver TransplantStatus unknownNCT00564538Phase 4
- Leflunomide + Methotrexate in Rheumatoid ArthritisCompletedNCT00563849Phase 4
- Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell TransplantationStatus unknownNCT00563108Not applicable
- Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and GemcitabineCompletedNCT00560963Phase 1/2
- Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2
- Pilot Open Label Clinical Trial With Abatacept in Ankylosing SpondylitisStatus unknownNCT00558506Phase 2
- Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based ImmunosuppressionCompletedNCT00555373Not applicable
- A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00555256Phase 1
- Top Down Versus Step Up Strategies in Crohn's DiseaseCompletedNCT00554710Phase 4
- Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan CriteriaStatus unknownNCT00554125Phase 3
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2
- Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV MelanomaCompletedNCT00553306Phase 1/2
- TACrolimus in Renal Transplantation: Individualization by PharmacogeneticCompletedNCT00552201Phase 4
- Cyclophosphamide and Celecoxib in Treating Patients With Advanced CancerCompletedNCT00551889Phase 1
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNCT00551265Not applicable